Radiopharmaceutical compounds are disclosed having a radionuclide chelating moiety and a targeting ligand, and optionally a linker. Formulations of compositions useful for making the radiopharmaceutical compounds contain a chelating ligand, a reducing agent, an exchange ligand and a stabilizer.
This application is the national stage application of corresponding international application number PCT/US03/13936 filed May 5, 2003 which claims priority to and the benefit of U.S. Provisional Application No. 60/377,454, filed May 3, 2002, all of which are hereby incorporated by reference.
